Manufacturing

Stockpiling excess inventory is no longer enough to respond to supply chain volatility.

Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.

The trends shaping the growth of the biologics outsourcing industry demand attention.

Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications.

The ROSS PDDM Planetary Dual Disperser offers flexibility in the form of removable disperser shafts.

Fluid Air’s Enhanced Magnaflo filter blowback system is designed to increase powder yield in PolarDry Models 001 and 004.

The IsoPick from iotaSciences is designed to expand handling solutions for cell biology and gene therapy applications.

Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

GAO calls for more oversight of institutional review boards in clinical trials.

Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.

Webinar Date/Time: Thu, Mar 23, 2023 11:00 AM EDT

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

Webinar Date/Time: Wed, Mar 1, 2023 11:00 AM EST

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.

Webinar Date/Time: Tue, Feb 28, 2023 2:00 PM EST

Webinar Date/Time: Thu, Feb 23, 2023 11:00 AM EST

Webinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

The change would impact every package and hundreds of systems.

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.